Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.13M Sell
31,267
-4,664
-13% -$302K 0.03% 701
2017
Q3
$2.21M Sell
35,931
-117,291
-77% -$7.2M 0.04% 641
2017
Q2
$9.63M Sell
153,222
-48,251
-24% -$2.75M 0.2% 106
2017
Q1
$11.2M Buy
201,473
+196,928
+4,333% +$10.1M 0.25% 85
2016
Q4
$217K Sell
4,545
-9,882
-68% -$554K 0.01% 1012
2016
Q3
$935K Sell
14,427
-70,475
-83% -$3.96M 0.03% 624
2016
Q2
$3.92M Sell
84,902
-100,195
-54% -$4.04M 0.21% 107
2016
Q1
$7.08M Buy
185,097
+70,743
+62% +$2.34M 0.44% 61
2015
Q4
$4.33M Buy
+114,354
New +$4.21M 0.34% 97

Other funds holding NUS

AHL Partners's NUS Position: Q4 2017 in Review

AHL Partners reduced its Nu Skin (NUS) stake by 13% in Q4 2017, selling an estimated $302K and leaving 31,267 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #701.

AHL Partners first reported a position in NUS in Q4 2015 and has held it in 9 quarters since. The position peaked at $11.2M in Q1 2017. 273 funds tracked by Wall St. Rank hold NUS as of Q4 2017.

  • AHL Partners held 31,267 shares of Nu Skin worth $2.13M as of Q4 2017.
  • AHL Partners sold 4,664 Nu Skin shares in Q4 2017, an estimated $302K.
  • Nu Skin made up 0.03% of AHL Partners's portfolio in Q4 2017, its #701 holding.
  • AHL Partners first reported a position in Nu Skin in Q4 2015 and has held it in 9 quarters since.
  • AHL Partners's Nu Skin position peaked at $11.2M in Q1 2017.
  • 273 funds tracked by Wall St. Rank held Nu Skin as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.